百奥赛图-B2024年度报告

百奧賽圖北京醫藥科技股份有限公司 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (A joint stock company incorporated in the People’s Republic of China with limited liability)（於中華人民共和國註冊成立的股份有限公司） Stock code股份代號：2315 ANNUAL REPORT年 度 報 告2024 Contents 2Corporate Information 6Definition 19Chairman’s Statement 22Management Discussion and Analysis 157Environmental, Social and Governance Report 197Appendix I: Summary of Internal Policies 199Appendix II: Environmental Key Performance IndicatorsSummary Table 201Appendix III: Index of HKEX’s Environmental, Social andGovernance Reporting Guide207Independent Auditor’s Report 214Consolidated Statements of Profit or Loss and OtherComprehensive Income215Consolidated Statements of Financial Position217Consolidated Statements of Changes in Equity218Consolidated Cash Flow Statements221Notes to the Consolidated Financial Statements336Financial Summary Corporate Information CHINESE NAME () ENGLISH NAME Biocytogen Pharmaceuticals(Beijing) Co., Ltd.* LEGAL REPRESENTATIVEDr. Shen Yuelei CHAIRMAN OF THE BOARDDr. Shen Yuelei HEAD OFFICES AND PRINCIPLE PLACE OFBUSINESS IN CHINA 12 12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District, BeijingPRC REGISTERED OFFICE 12 12 Baoshen South StreetDaxing Bio-Medicine Industry ParkDaxing District, BeijingPRC PRINCIPAL PLACE OF BUSINESS IN HONGKONG 24840 40th Floor, Dah Sing Financial CenterNo. 248 Queen’s Road EastWanchaiHong Kong Corporate Information BOARD OF DIRECTORS Executive Directors Dr. Shen Yuelei(Chairman, Chief Executive Officer and General Manager)Dr. Ni JianDr. Zhang Haichao(Senior Operation Director of Animal Center) Non-executive Directors Mr. Wei YiliangDr. Zhou KexiangMs. Zhang Leidi Independent Non-executive Directors Mr. Hua FengmaoDr. Yu ChangyuanMs. Liang Xiaoyan SUPERVISORS Ms. Li YanMs. Sun ChunliDr. Yao Jiawei AUDIT COMMITTEE Ms. Liang Xiaoyan(Chairman)Mr. Hua FengmaoDr. Yu ChangyuanMr. Wei Yiliang REMUNERATION AND EVALUATIONCOMMITTEE Mr. Hua Fengmao(Chairman)Ms. Liang XiaoyanDr. Yu ChangyuanDr. Ni Jian Corporate Information NOMINATION COMMITTEE Dr. Yu Changyuan(Chairman)Mr. Hua FengmaoMs. Liang XiaoyanDr. Shen Yuelei STRATEGY DEVELOPMENT COMMITTEE Dr. Shen Yuelei(Chairman)Dr. Zhou KexiangMr. Wei YiliangMs. Zhang Leidi JOINT COMPANY SECRETARIES Mr. Wang YongliangMs. Au Wai Ching(fellow member of The Hong Kong CharteredGovernance Institute and The Chartered Governance Institute inthe United Kingdom) AUTHORIZED REPRESENTATIVES Dr. Shen YueleiMs. Au Wai Ching AUDITOR 108 KPMGPublic Interest Entity Auditor registered in accordance withthe Accounting and Financial Reporting Council Ordinance8th Floor, Prince’s Building10 Chater RoadCentral, Hong Kong PRINCIPAL BANKS China Construction Bank Beijing Economic and TechnologicalDevelopment Zone Sub-branchNo. 2, Jingyuan North StreetDaxing DistrictBeijing, PRC 2 881 China Merchants Bank, Beijing Yizhuang Sub-branch1/F, Building 8, Libao PlazaNo. 8 Ronghua Middle RoadDaxing DistrictBeijing, PRC Corporate Information H H SHARE REGISTRAR 1617 Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong LEGAL ADVISERS TO HONG KONG LAW 3A10 Davis Polk & Wardwell10th Floor, The Hong Kong Club Building3A Chater Road, Hong Kong 02315 STOCK CODE 02315 COMPANY WEBSITE http://www.biocytogen.com.cn http://www.biocytogen.com.cn CONTACT INFORMATION FOR INVESTORS Tel.: 010-56967601Fax: 010-56967666-8067Email: ir@bbctg.com.cn 010-56967601010-56967666-8067ir@bbctg.com.cn Definition “Adoption Date” “Articles” or “Articles ofAssociation” “Audit Committee” Definition Definition Definition “Domestic Share(s)” 1.0ordinary share(s) issued by our Company, with a nominal value of RMB1.0each, which are subscribed for or credited as paid in Renminbi “Employee(s)” anyfull-time employee(excluding any Excluded Employee)of anymember of the Group (i)1(ii) “Excluded Employee(s)” (i) at the time of the proposed grant of an Award, any Employee whoseservice in the Group does not exceed 1 year from the expiry date of hisprobationary period as stated in his employment contract with the Group,except as otherwise determined by the Board at its absolute discretionon a case by case basis, or (ii) any Employee who is resident in a placewhere the award of the Awarded Shares and/or the vesting and transfer ofthe Awarded Shares pursuant to the terms of the Scheme is not permittedunder the laws and regulations of such place or where in the view of theBoard or the Trustee (as the case may be), compliance with applicablelaws and regulations in such place makes it necessary or expedient toexclude such Employee “Employee Incentive Platforms” BaiaoEvergreen,Baiao Changsheng,Eucure Evergreen and EucureChangsheng “Employee Incentive Schemes” the employee incentive schemes of our Company approved and adoptedby the Board “Eucure Changsheng” 202091Shanghai Eucure Changsheng Technology Development Center (Limited